Real-Time and Accelerated Stability Studies for Biologics
Real-Time and Accelerated Stability Studies for Biologics Comprehensive Guide to Real-Time and Accelerated Stability Studies for Biologics Introduction Biologics, including monoclonal antibodies, recombinant proteins, vaccines, and biosimilars, are among the most complex and sensitive pharmaceuticals. Ensuring their stability over time is essential for regulatory approval, therapeutic efficacy, and patient safety. Real-time and accelerated Stability Studies…
Read More “Real-Time and Accelerated Stability Studies for Biologics” »